In November 2022, Biocon Limited, an innovation-driven global biopharmaceutical company, signed a semi-exclusive partnership agreement with Zentiva, a leading European pharmaceutical company, to commercialize Liraglutide, a vertically integrated, complex formulation for the treatment and management of Type 2 diabetes and obesity
S4), suggesting a lack of publication bias
The cost-sharing for Bridge does not apply to annual maximums, and all prescriptions will be adjudicated by a single administrator, Humana, which only began accepting prior authorization requests on July 1
But it's manageable with the right support
Cases were claimed to be successfully cured with antibiotics and dietary changes as above